Human leukocyte antigen polymorphism in chronic and aggressive periodontitis among Caucasians: a meta-analysis.

Department of Operative Dentistry, Periodontology and Preventive Dentistry, University Hospital (RWTH), Aachen, Germany.
Journal Of Clinical Periodontology (Impact Factor: 3.61). 04/2008; 35(3):183-92. DOI: 10.1111/j.1600-051X.2007.01189.x
Source: PubMed

ABSTRACT Multiple studies have reported associations between periodontitis and particular human leukocyte antigens (HLA). Because associations are inconsistent, we conducted a systematic literature review and a meta-analysis focusing on Caucasian case-control studies.
A literature search reporting on the distribution of HLA class I and II phenotypes in Caucasian patients with chronic periodontitis (CP) and aggressive periodontitis (AP) was performed. Data sources included electronic databases and bibliographies of published articles. Screening and data abstraction were conducted independently by different reviewers.
Out of 174 publications, 12 studies were considered to be suitable for meta-analysis. In patients with CP, no significant HLA associations were found. Patients with AP showed a positive association with HLA-A9 [odds ratio=2.59 (95% confidence interval 1.36-4.83), p=0.004] and HLA-B15 [1.90 (1.15-3.16), p=0.01] as well as a negative association with HLA-A2 [0.72 (0.56-0.94), p=0.01] and -B5 [0.49 (0.30-0.79), p=0.004]. On grouping all patients into one periodontitis group (AP+CP), the same deviations were confirmed with higher statistical significance. For HLA-A9 and -B15, significant heterogeneity was found between the studies. No significant associations were found with HLA class II antigens.
HLA-A9 and -B15 seem to represent susceptibility factors for AP whereas HLA-A2 and -B5 are potential protective factors against periodontitis among Caucasians.


Available from: Jamal M. Stein, Sep 07, 2014
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Human leukocyte antigens (HLA) are crucial components of host defense against microbial challenge but the associations of HLA types with oral infectious diseases have not been studied in detail. This prospective cross-sectional study examined associations of HLA-A, -B and -DRB1 types with common oral diseases in a healthy Swiss adult population. 257 subjects (107 m, 150 f, mean age: 43.5 yr; range: 21-58 yr) with known HLA-A, -B and -DRB1 profiles and comprehensive medical records were included. A thorough anamnesis was followed by oral examinations including saliva flow measurements, the DMFT score for cariological status, complete periodontal status with plaque and bleeding indexes as well as assessment of mucosal alterations and temporomandibular dysfunction (TMD). Student's t-test and Pearson chi-square test were utilized to compare the oral diseases between HLA positive and negative subjects. Bonferroni correction for multiple comparisons was used and PBonf<0.05 was considered statistically significant. HLA types -B15 (PBonf = 0.002), -B51 (PBonf = 0.02) and -DRB1*12 (PBonf = 0.02) were associated with less periodontal disease manifestations. HLA-A32 had a positive association with TMD dysfunction (PBonf = 0.012). No other statistically significant associations were observed. In conclusion, HLA types may contribute to the development of oral diseases in generally healthy Caucasian adults.
    PLoS ONE 07/2014; 9(7):e103527. DOI:10.1371/journal.pone.0103527 · 3.53 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Background: Periodontal disease, which affects tooth-supporting structures, results from disequilibrium between the oral micro flora and host defense mecha-nisms. It has been classified into chronic (CP) or ag-gressive (AP) periodontitis according to disease onset, localization and progression. Because of their invol-vement in generating immune responses, Human Leukocyte Antigen (HLA) alleles are considered can-didate genetic risk markers for periodontitis. Addi-tionally, periodontitis appears to contribute to the severity of some systemic conditions such as cardio-vascular disease and adverse pregnancy outcome as indicated by elevated levels of C-reactive protein (CRP). Aim: The aims of this study were to deter-mine if there is an HLA-AP association in Lebanese patients, and to determine CRP levels in patients and compare them to those in healthy controls. Materials and methods: The study groups included 26 patients with AP and 39 healthy controls. HLA profiles were determined by DNA typing and CRP levels by ELI-SA. Results: HLA-A*30 (P-value = 0.010), HLA-B*41 (P 1 = 0.012 and P 2 = 0.014), HLA-DRB1*13 (P 1 = 0.031 and P 2 = 0.063) alleles seemed to be associ-ated with protection against AP in Lebanese patients. No linkage disequilibrium existed between alleles associated with AP. Ten of 26 AP patients (38.5%) and 10 of 39 (25.7%) controls had elevated CRP lev-els. Conclusion: In conclusion, protective, but no sus-ceptible HLA alleles were detected in AP. CRP levels were not elevated in the entire AP group, and were not significantly different from controls. No linkage disequilibrium existed between alleles.
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Aim: The aim of this study was to study if generalized aggressive periodontitis (GAP) have similar survival rates (SR) and marginal bone loss (MBL) when compared to chronic periodontitis (CP) and/or healthy patients (HP). Methods: An electronic literature search was conducted by one reviewer (AM) in several databases from 2000 to 2013, including MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Oral Health Group Trials Register database for articles written in English up to November 2013. Human clinical trials, either prospective or retrospective, that compared implant survival rate (SR) and marginal bone loss (MBL) in patients with history of GAP versus the patients with CP or HP were included. Results: A total of 6 non-randomized prospective clinical trials met the inclusion criteria. Our results show a SR of 83.3-100% (GAP), 96.4-100% (CP), and 96.9-100% (HP) over a mean period of 48.01±71.99 months, with an overall risk ratio of 0.96 (95% CI= 0.91 to 1.01, p=0.14) (GAP vs. HP) and 0.94 (95% CI= 0.87 to 1.01, p=0.09) (GAP vs. CP). However, when we examined the “failure rate” as studied outcome, meta-analysis presented an overall risk ratio of 4.00 for the comparison between patients with AP and HP, and an overall risk ratio of 3.97 when compared to patients with CP. The marginal bone loss weighted mean difference for each subgroup was 0.15mm (95% CI= 0.04 to 0.26) (HP vs. CP), -0.28mm (95% CI= -0.36 to -0.19) (HP vs. GAP), and -0.43mm (95% CI= -0.53 to -0.33) (CP vs. GAP) over a mean period of 30±18 months. Conclusion: Implant placement in patients with history of generalized aggressive periodontitis might be considered a viable option to restore oral function with similar survival outcomes as of those found in both healthy and chronic periodontitis patients. However, the risk ratio for failure in patients with AP is significantly higher when compared to HP (4.0) and CP (3.97).